Identification and metabolic transformations of carotenoids in ocular tissues of the Japanese quail Coturnix japonica.

PubWeight™: 1.11‹?› | Rank: Top 10%

🔗 View Article (PMC 2531157)

Published in Biochemistry on July 14, 2007

Authors

Prakash Bhosale1, Bogdan Serban, Da You Zhao, Paul S Bernstein

Author Affiliations

1: Department of Ophthalmology and Visual Sciences, Moran Eye Center, University of Utah School of Medicine, 65 Medical Drive, Salt Lake City, Utah 84132, USA.

Associated clinical trials:

The Role of Macular Pigment Carotenoids in the Pathogenesis and Treatment of Macular Telangiectasia Type 2 (MacTel) | NCT01354093

Articles citing this

Retinal carotenoids can attenuate formation of A2E in the retinal pigment epithelium. Arch Biochem Biophys (2008) 1.18

Noninvasive assessment of dermal carotenoids as a biomarker of fruit and vegetable intake. Am J Clin Nutr (2010) 1.17

The value of measurement of macular carotenoid pigment optical densities and distributions in age-related macular degeneration and other retinal disorders. Vision Res (2009) 1.11

What is meso-zeaxanthin, and where does it come from? Eye (Lond) (2013) 1.10

Lutein, zeaxanthin, and meso-zeaxanthin: The basic and clinical science underlying carotenoid-based nutritional interventions against ocular disease. Prog Retin Eye Res (2015) 0.98

Verification of Meso-Zeaxanthin in Fish. J Food Process Technol (2014) 0.93

Inactivity of human β,β-carotene-9',10'-dioxygenase (BCO2) underlies retinal accumulation of the human macular carotenoid pigment. Proc Natl Acad Sci U S A (2014) 0.91

The role of lutein in eye-related disease. Nutrients (2013) 0.89

Significant correlations of dermal total carotenoids and dermal lycopene with their respective plasma levels in healthy adults. Arch Biochem Biophys (2010) 0.88

Comment on: What is meso-zeaxanthin, and where does it come from? Eye (Lond) (2013) 0.86

Macular response to supplementation with differing xanthophyll formulations in subjects with and without age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (2014) 0.85

Zeaxanthin inhibits hypoxia-induced VEGF secretion by RPE cells through decreased protein levels of hypoxia-inducible factors-1α. Biomed Res Int (2015) 0.82

Assessment of lutein, zeaxanthin and meso-zeaxanthin concentrations in dietary supplements by chiral high-performance liquid chromatography. Eur Food Res Technol (2015) 0.80

Complementary shifts in photoreceptor spectral tuning unlock the full adaptive potential of ultraviolet vision in birds. Elife (2016) 0.77

Developmentally Regulated Production of meso-Zeaxanthin in Chicken Retinal Pigment Epithelium/Choroid and Retina. Invest Ophthalmol Vis Sci (2016) 0.76

Retinal accumulation of zeaxanthin, lutein, and β-carotene in mice deficient in carotenoid cleavage enzymes. Exp Eye Res (2017) 0.75

MACULAR PIGMENT DISTRIBUTION RESPONSES TO HIGH-DOSE ZEAXANTHIN SUPPLEMENTATION IN PATIENTS WITH MACULAR TELANGIECTASIA TYPE 2. Retina (2017) 0.75

Articles cited by this

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol (2001) 21.37

Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. JAMA (1994) 5.43

Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11. Arch Ophthalmol (2003) 3.17

Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye. Annu Rev Nutr (2003) 2.63

Carotenoid actions and their relation to health and disease. Mol Aspects Med (2005) 2.59

Antioxidant status and neovascular age-related macular degeneration. Eye Disease Case-Control Study Group. Arch Ophthalmol (1993) 2.24

Analysis of the macular pigment by HPLC: retinal distribution and age study. Invest Ophthalmol Vis Sci (1988) 1.96

Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). Optometry (2004) 1.73

Dietary modification of human macular pigment density. Invest Ophthalmol Vis Sci (1997) 1.72

The cone oil droplets of avian retinas. Vision Res (1984) 1.65

Distribution of lutein and zeaxanthin stereoisomers in the human retina. Exp Eye Res (1997) 1.62

Nutritional manipulation of primate retinas, III: Effects of lutein or zeaxanthin supplementation on adipose tissue and retina of xanthophyll-free monkeys. Invest Ophthalmol Vis Sci (2005) 1.62

Identification of lutein and zeaxanthin oxidation products in human and monkey retinas. Invest Ophthalmol Vis Sci (1997) 1.60

Identification and quantitation of carotenoids and their metabolites in the tissues of the human eye. Exp Eye Res (2001) 1.46

A one year study of the macular pigment: the effect of 140 days of a lutein supplement. Exp Eye Res (1997) 1.45

Influence of lutein supplementation on macular pigment, assessed with two objective techniques. Invest Ophthalmol Vis Sci (2000) 1.34

Carotenoids in the human macula and whole retina. Invest Ophthalmol Vis Sci (1988) 1.31

In vivo resonant Raman measurement of macular carotenoid pigments in the young and the aging human retina. J Opt Soc Am A Opt Image Sci Vis (2002) 1.30

Transformations of selected carotenoids in plasma, liver, and ocular tissues of humans and in nonprimate animal models. Invest Ophthalmol Vis Sci (2002) 1.28

Lutein and zeaxanthin status and risk of age-related macular degeneration. Invest Ophthalmol Vis Sci (2003) 1.25

Anhydrolutein in the zebra finch: a new, metabolically derived carotenoid in birds. Comp Biochem Physiol B Biochem Mol Biol (2002) 1.23

Metabolism, nutrition, and function of carotenoids. Annu Rev Nutr (1986) 1.21

The body of evidence to support a protective role for lutein and zeaxanthin in delaying chronic disease. Overview. J Nutr (2002) 1.20

Nutritional manipulation of primate retinas, I: effects of lutein or zeaxanthin supplements on serum and macular pigment in xanthophyll-free rhesus monkeys. Invest Ophthalmol Vis Sci (2004) 1.15

HPLC measurement of ocular carotenoid levels in human donor eyes in the lutein supplementation era. Invest Ophthalmol Vis Sci (2007) 0.96

Identification of 3-methoxyzeaxanthin as a novel age-related carotenoid metabolite in the human macula. Invest Ophthalmol Vis Sci (2007) 0.95

Long term dietary supplementation with zeaxanthin reduces photoreceptor death in light-damaged Japanese quail. Exp Eye Res (2002) 0.91

Quantitative measurement of 3'-oxolutein from human retina by normal-phase high-performance liquid chromatography coupled to atmospheric pressure chemical ionization mass spectrometry. Anal Biochem (2005) 0.91

Chronic ingestion of (3R,3'R,6'R)-lutein and (3R,3'R)-zeaxanthin in the female rhesus macaque. Invest Ophthalmol Vis Sci (2006) 0.84

Effect of dietary zeaxanthin on tissue distribution of zeaxanthin and lutein in quail. Invest Ophthalmol Vis Sci (2002) 0.82

Production of deuterated lutein by Chlorella protothecoides and its detection by mass spectrometric methods. Biotechnol Lett (2006) 0.82

The selective retention of lutein, meso-zeaxanthin and zeaxanthin in the retina of chicks fed a xanthophyll-free diet. Exp Eye Res (2007) 0.82

Production of deuterated zeaxanthin by Flavobacterium multivorum and its detection by resonance Raman and mass spectrometric methods. Biotechnol Lett (2005) 0.80

3'-Oxolutein, a metabolite of lutein in chickens. Poult Sci (1986) 0.77

Experimental light damage increases lipofuscin in the retinal pigment epithelium of Japanese quail (Coturnix coturnix japonica). Exp Eye Res (1993) 0.77

Supplementation of the maternal diet with tomato powder and marigold extract: effects on the antioxidant system of the developing quail. Br Poult Sci (2006) 0.77

Articles by these authors

A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science (2006) 5.67

Toll-like receptor 3 and geographic atrophy in age-related macular degeneration. N Engl J Med (2008) 4.46

Characterization of an Arabidopsis enzyme family that conjugates amino acids to indole-3-acetic acid. Plant Cell (2005) 3.88

Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC). Proc Natl Acad Sci U S A (2010) 3.33

CFH Y402H confers similar risk of soft drusen and both forms of advanced AMD. PLoS Med (2005) 2.01

Effect of age and other factors on macular pigment optical density measured with resonance Raman spectroscopy. Graefes Arch Clin Exp Ophthalmol (2014) 1.99

Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications. Proc Natl Acad Sci U S A (2008) 1.70

Chemistry, distribution, and metabolism of tomato carotenoids and their impact on human health. Exp Biol Med (Maywood) (2002) 1.66

Identification and characterization of a Pi isoform of glutathione S-transferase (GSTP1) as a zeaxanthin-binding protein in the macula of the human eye. J Biol Chem (2004) 1.60

HTRA1 variant confers similar risks to geographic atrophy and neovascular age-related macular degeneration. Cell Cycle (2007) 1.53

Vitamin A in the cerebrospinal fluid of patients with and without idiopathic intracranial hypertension. Ann Neurol (2002) 1.50

Identification of StARD3 as a lutein-binding protein in the macula of the primate retina. Biochemistry (2011) 1.43

In vivo resonant Raman measurement of macular carotenoid pigments in the young and the aging human retina. J Opt Soc Am A Opt Image Sci Vis (2002) 1.30

Transformations of selected carotenoids in plasma, liver, and ocular tissues of humans and in nonprimate animal models. Invest Ophthalmol Vis Sci (2002) 1.28

Purification and partial characterization of a lutein-binding protein from human retina. Biochemistry (2009) 1.27

A rare nonsynonymous sequence variant in C3 is associated with high risk of age-related macular degeneration. Nat Genet (2013) 1.23

Transport and retinal capture of lutein and zeaxanthin with reference to age-related macular degeneration. Surv Ophthalmol (2008) 1.19

ARMS2/HTRA1 locus can confer differential susceptibility to the advanced subtypes of age-related macular degeneration. Am J Ophthalmol (2010) 1.19

Nonmydriatic fluorescence-based quantitative imaging of human macular pigment distributions. J Opt Soc Am A Opt Image Sci Vis (2006) 1.18

Retinal carotenoids can attenuate formation of A2E in the retinal pigment epithelium. Arch Biochem Biophys (2008) 1.18

Studies on the singlet oxygen scavenging mechanism of human macular pigment. Arch Biochem Biophys (2010) 1.17

Noninvasive assessment of dermal carotenoids as a biomarker of fruit and vegetable intake. Am J Clin Nutr (2010) 1.17

Human ocular carotenoid-binding proteins. Photochem Photobiol Sci (2010) 1.16

Assessing susceptibility to age-related macular degeneration with genetic markers and environmental factors. Arch Ophthalmol (2011) 1.10

Microbial xanthophylls. Appl Microbiol Biotechnol (2005) 1.08

Synergistic effects of zeaxanthin and its binding protein in the prevention of lipid membrane oxidation. Biochim Biophys Acta (2005) 1.07

Long-chain and very long-chain polyunsaturated fatty acids in ocular aging and age-related macular degeneration. J Lipid Res (2010) 1.03

Vertebrate and invertebrate carotenoid-binding proteins. Arch Biochem Biophys (2006) 1.02

Genetic determinants of macular pigments in women of the Carotenoids in Age-Related Eye Disease Study. Invest Ophthalmol Vis Sci (2013) 0.99

26th Hohenheim Consensus Conference, September 11, 2010 Scientific substantiation of health claims: evidence-based nutrition. Nutrition (2011) 0.99

Macular pigment Raman detector for clinical applications. J Biomed Opt (2004) 0.98

HPLC measurement of ocular carotenoid levels in human donor eyes in the lutein supplementation era. Invest Ophthalmol Vis Sci (2007) 0.96

Association of adipose and red blood cell lipids with severity of dominant Stargardt macular dystrophy (STGD3) secondary to an ELOVL4 mutation. Arch Ophthalmol (2006) 0.96

Resonance Raman imaging of macular pigment distributions in the human retina. J Opt Soc Am A Opt Image Sci Vis (2008) 0.96

Photophysical properties of xanthophylls in carotenoproteins from human retinas. Photochem Photobiol (2003) 0.95

Identification of 3-methoxyzeaxanthin as a novel age-related carotenoid metabolite in the human macula. Invest Ophthalmol Vis Sci (2007) 0.95

Genetic evidence for role of carotenoids in age-related macular degeneration in the Carotenoids in Age-Related Eye Disease Study (CAREDS). Invest Ophthalmol Vis Sci (2014) 0.95

Macular carotenoid levels of normal subjects and age-related maculopathy patients in a Japanese population. Ophthalmology (2008) 0.94

Microbial carotenoids. Methods Mol Biol (2012) 0.93

Resonance Raman measurement of macular carotenoids in retinal, choroidal, and macular dystrophies. Arch Ophthalmol (2003) 0.93

Role of ELOVL4 and very long-chain polyunsaturated fatty acids in mouse models of Stargardt type 3 retinal degeneration. Proc Natl Acad Sci U S A (2013) 0.92

Quantitative measurement of 3'-oxolutein from human retina by normal-phase high-performance liquid chromatography coupled to atmospheric pressure chemical ionization mass spectrometry. Anal Biochem (2005) 0.91

Surface plasmon resonance (SPR) studies on the interactions of carotenoids and their binding proteins. Arch Biochem Biophys (2012) 0.88

Postcataract endophthalmitis caused by Mycobacterium goodii. J Cataract Refract Surg (2005) 0.88

Significant correlations of dermal total carotenoids and dermal lycopene with their respective plasma levels in healthy adults. Arch Biochem Biophys (2010) 0.88

Carotenoids as possible interphotoreceptor retinoid-binding protein (IRBP) ligands: a surface plasmon resonance (SPR) based study. Arch Biochem Biophys (2013) 0.86

Retinoid receptors trigger neuritogenesis in retinal degenerations. FASEB J (2011) 0.86

Dietary modification and moderate antioxidant supplementation differentially affect serum carotenoids, antioxidant levels and markers of oxidative stress in older humans. J Nutr (2003) 0.85

Retinol-binding protein and retinol analysis in cerebrospinal fluid and serum of patients with and without idiopathic intracranial hypertension. J Neuroophthalmol (2007) 0.85

Production of deuterated lutein by Chlorella protothecoides and its detection by mass spectrometric methods. Biotechnol Lett (2006) 0.82

Resonance Raman based skin carotenoid measurements in newborns and infants. J Biophotonics (2012) 0.82

Demographic characteristics, patterns and risk factors for retinal vein occlusion in Nepal: a hospital-based case-control study. Clin Experiment Ophthalmol (2010) 0.82

Intravitreal injection of triamcinolone acetonide for macular edema due to retinitis pigmentosa and other retinal diseases. Adv Exp Med Biol (2006) 0.81

Noninvasive detection of macular pigments in the human eye. J Biomed Opt (2004) 0.81

Identification of a potential susceptibility locus for macular telangiectasia type 2. PLoS One (2012) 0.80

Production of deuterated zeaxanthin by Flavobacterium multivorum and its detection by resonance Raman and mass spectrometric methods. Biotechnol Lett (2005) 0.80

Resonance Raman quantification of nutritionally important carotenoids in fruits, vegetables, and their juices in comparison to high-pressure liquid chromatography analysis. J Agric Food Chem (2004) 0.79

Comprehensive and sensitive quantification of long-chain and very long-chain polyunsaturated fatty acids in small samples of human and mouse retina. J Chromatogr A (2013) 0.79

Beta-carotene production by Flavobacterium multivorum in the presence of inorganic salts and urea. J Ind Microbiol Biotechnol (2004) 0.79

Diagnostic and therapeutic challenges. Retina (2008) 0.78

Temporal macular thinning associated with X-linked Alport syndrome. JAMA Ophthalmol (2013) 0.78

Raman imaging of human macular pigments. Opt Lett (2002) 0.78

Rethinking A2E. Invest Ophthalmol Vis Sci (2013) 0.78

Single v. multiple measures of skin carotenoids by resonance Raman spectroscopy as a biomarker of usual carotenoid status. Br J Nutr (2013) 0.77

10q26 is associated with increased risk of age-related macular degeneration in the Utah population. Adv Exp Med Biol (2008) 0.77

Interrelationships between maternal carotenoid status and newborn infant macular pigment optical density and carotenoid status. Invest Ophthalmol Vis Sci (2013) 0.77

Assessment of the validity of in vivo methods of measuring human macular pigment optical density. Optom Vis Sci (2006) 0.77

Quantification of macular carotenoids using autofluorescence imaging in patients with photosensitive migraine and benign essential blepharospasm. Arch Ophthalmol (2012) 0.76

Developmentally Regulated Production of meso-Zeaxanthin in Chicken Retinal Pigment Epithelium/Choroid and Retina. Invest Ophthalmol Vis Sci (2016) 0.76

Correction: Relationship between Concentrations of Lutein and StARD3 among Pediatric and Geriatric Human Brain Tissue. PLoS One (2016) 0.75

Reflection-based imaging of macular pigment distributions in infants and children. J Biomed Opt (2013) 0.75

Macular and serum carotenoid concentrations in patients with malabsorption syndromes. J Ocul Biol Dis Infor (2008) 0.75

Effect of age and other factors on macular pigment optical density measured with resonance Raman spectroscopy. Graefes Arch Clin Exp Ophthalmol (2014) 0.75

EZOGABINE (POTIGA) MACULOPATHY. Retin Cases Brief Rep (2016) 0.75

Resonant Raman quantification of zeaxanthin production from Flavobacterium multivorum. Biotechnol Lett (2003) 0.75

Awareness of diabetic retinopathy among diabetic patients in Nepal. Acta Ophthalmol (2011) 0.75

Evaluation of 4-methylpyrazole as a potential therapeutic dark adaptation inhibitor. Curr Eye Res (2007) 0.75

Intravitreal Versus Subretinal Tissue Plasminogen Activator Injection for Submacular Hemorrhage. Ophthalmic Surg Lasers Imaging Retina (2017) 0.75